As an alternative approach to drug discovery, we conducted an unbiased high-throughput screen of the library of Pharmacologically Active Compounds (LOPAC) using viability of merlin-mutant mouse Schwann cells (MSC) as a phenotypic assay to identify potential compounds and pathways relevant to NF2 schwannoma treatment. The gene discussed is NF2; the disease is schwannoma.